Clinical Outcomes for Newly Diagnosed Diabetes Patients in Korea: A National Health Insurance Data

ABSTRACT Aims The early clinical impact of type 2 diabetes is not fully understood due to uncertainties surrounding the timing of disease onset. We assessed clinical outcomes in patients newly diagnosed with type 2 diabetes and without preexisting comorbidities, utilising the Korean National Health Insurance Service database. Materials and Methods We identified patients (20–80 years) newly diagnosed with type 2 diabetes without prior atherosclerotic cardiovascular or kidney disease (eGFR < 60 mL/min/1.73 m 2 , albuminuria, or relevant ICD codes). Age‐ and sex‐matched controls were selected (1:4). Primary outcomes included ischemic/hemorrhagic stroke, myocardial infarction, heart failure, chronic kidney disease (CKD) progression to eGFR < 60 mL/min/1.73 m 2 , renal replacement therapy (RRT), and all‐cause mortality. Results Among 2 164 060 individuals, 432 812 were newly diagnosed with type 2 diabetes. Participants were followed for a median of 5.1 years (IQR 3.3–6.2 years; maximum follow‐up 7.6 years). After adjusting for covariates, the risks in the type 2 diabetes group remained significantly elevated compared to the controls: total composite outcome (hazard ratio, HR [95% confidence interval, CI]: 1.67 [1.64–1.70]), non‐renal composite outcome (1.57 [1.53–1.60]), renal composite outcome (1.86 [1.82–1.90]), and individual outcomes including ischemic stroke (1.73 [1.66–1.80]), hemorrhagic stroke (1.24 [1.14–1.35]), myocardial infarction (1.84 [1.73–1.95]), heart failure (2.17 [2.08–2.27]), CKD progression (1.47 [1.41–1.53]), RRT (4.17 [3.51–4.95]), and all‐cause mortality (1.14 [1.10–1.19]). Conclusions Patients newly diagnosed with type 2 diabetes faced substantially increased risks of cardiovascular, renal complications, and all‐cause mortality, despite preserved baseline kidney function. Proactive risk assessments and preventive strategies are needed to mitigate the long‐term burden of diabetes‐related complications.

Authors

Institutions

Publication Details

Journal
Diabetes Obesity and Metabolism
Published
2026-07-16
DOI
https://doi.org/10.1111/dom.71116
Primary Topic
Diabetes, Cardiovascular Risks, and Lipoproteins
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Clinical Outcomes for Newly Diagnosed Diabetes Patients in Korea: A National Health Insurance Data

Samel Park, Sang Youb Han, Hyun Jung Kim, Hyung Woo Kim et al.
Diabetes Obesity and Metabolism
Diabetes, Cardiovascular Risks, and Lipoproteins
article

Clinical Outcomes for Newly Diagnosed Diabetes Patients in Korea: A National Health Insurance Data

Samel Park, Sang Youb Han, Hyun Jung Kim, Hyung Woo Kim, Sun-Hee Park
article en

Abstract

ABSTRACT Aims The early clinical impact of type 2 diabetes is not fully understood due to uncertainties surrounding the timing of disease onset. We assessed clinical outcomes in patients newly diagnosed with type 2 diabetes and without preexisting comorbidities, utilising the Korean National Health Insurance Service database. Materials and Methods We identified patients (20–80 years) newly diagnosed with type 2 diabetes without prior atherosclerotic cardiovascular or kidney disease (eGFR < 60 mL/min/1.73 m 2 , albuminuria, or relevant ICD codes). Age‐ and sex‐matched controls were selected (1:4). Primary outcomes included ischemic/hemorrhagic stroke, myocardial infarction, heart failure, chronic kidney disease (CKD) progression to eGFR < 60 mL/min/1.73 m 2 , renal replacement therapy (RRT), and all‐cause mortality. Results Among 2 164 060 individuals, 432 812 were newly diagnosed with type 2 diabetes. Participants were followed for a median of 5.1 years (IQR 3.3–6.2 years; maximum follow‐up 7.6 years). After adjusting for covariates, the risks in the type 2 diabetes group remained significantly elevated compared to the controls: total composite outcome (hazard ratio, HR [95% confidence interval, CI]: 1.67 [1.64–1.70]), non‐renal composite outcome (1.57 [1.53–1.60]), renal composite outcome (1.86 [1.82–1.90]), and individual outcomes including ischemic stroke (1.73 [1.66–1.80]), hemorrhagic stroke (1.24 [1.14–1.35]), myocardial infarction (1.84 [1.73–1.95]), heart failure (2.17 [2.08–2.27]), CKD progression (1.47 [1.41–1.53]), RRT (4.17 [3.51–4.95]), and all‐cause mortality (1.14 [1.10–1.19]). Conclusions Patients newly diagnosed with type 2 diabetes faced substantially increased risks of cardiovascular, renal complications, and all‐cause mortality, despite preserved baseline kidney function. Proactive risk assessments and preventive strategies are needed to mitigate the long‐term burden of diabetes‐related complications.

Diabetes Obesity and Metabolism
Yonsei University (KR), Korea University (KR), Soonchunhyang University (KR), Kyungpook National University (KR), Inje University Ilsan Paik Hospital (KR)
Openalex Percentile: Top 8%
Diabetes, Cardiovascular Risks, and Lipoproteins
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.